Sample Page

This article is rated Start-class on Wikipedia’s content assessment scale. It is of interest to the following WikiProjects:

Biography: Science and Academia This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia’s articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography This article is supported by the science and academia work group. United States This article is within the scope of WikiProject United States, a collaborative effort to improve the coverage of topics relating to the United States of America on Wikipedia. If you would like to participate, please visit the project page, where you can join the ongoing discussions. Template Usage Articles Requested! Become a Member Project Talk Alerts United StatesWikipedia:WikiProject United StatesTemplate:WikiProject United StatesUnited States ??? This article has not yet received a rating on the project’s importance scale. Women scientists Low‑importance This article is within the scope of WikiProject Women scientists, a collaborative effort to improve the coverage of Women in science on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Women scientistsWikipedia:WikiProject Women scientistsTemplate:WikiProject Women scientistsWomen scientists Low This article has been rated as Low-importance on the project’s importance scale.

Hello all,

I received a warning when making some edits to the page regarding blogspot as a cited source. While I would normally agree that blogs are not good source material the site in question was written by UBeam’s former Chief Technology Officer and provides some excellent inside information regarding the innerworkings and news about UBeam. — Preceding unsigned comment added by 2001:56A:F901:C900:428D:5CFF:FEB0:F473 (talk) 18:32, 17 November 2020 (UTC)[reply]

This page should really address Meredith’s controversial statements on engineering. In her TED talk, she explicitly defamed the entire field and made overall unrealistic claims about energy transmission. It is evident her claims were unfounded and scientifically unsound, having wasted millions towards the (unfulfilled) energy transmission promise. An unassuming reader of Wikipedia reaching the current page would end up with a biased self-promoted/vanity picture of this person.

She appears to meet GNG. And aren’t the WP:ABOUTSELF usable for info about her age and career and stuff? Andre🚐 23:07, 20 December 2023 (UTC)[reply]

Correct. WikiEditor020575 (talk) 20:41, 10 January 2024 (UTC)[reply]

I’ve made some revisions to the lead and the career section to improve neutrality and attribution. Specifically, I removed editorial phrasing such as “failed startup”, “ignored criticism”, and “failed attempts”, which were not written in a neutral tone and risked implying conclusions not directly supported by sources. The article now describes uBeam as a company that claimed to develop ultrasound-based wireless charging but did not produce a commercial product, with feasibility concerns attributed to published experts and former engineers. Perry’s 2018 departure as CEO is described in the context of the company’s reported pivot toward business-to-business licensing, based on TechCrunch and Axios.

If other editors have suggestions for further refinements, especially with additional reliable sources, please chime in! Jonatan Svensson Glad (talk) 09:51, 20 August 2025 (UTC)[reply]

I am disclosing a conflict of interest per WP:COI and requesting that uninvolved editors review and, if appropriate, implement the following proposed changes to this biography of a living person.

Proposed Edit 1: Opening line Current text: “best known as the founder of uBeam, a company that claimed to develop wireless charging technology using ultrasound but did not succeed in producing a commercial product.”

Proposed text: “best known as the inventor of ultrasonic wireless power transmission.”

Rationale:

The current opening has multiple problems under WP:BLP, WP:NPOV, and WP:LABEL: (a) “Claimed to develop” is factually inaccurate and pejorative. The subject is the named inventor on 25 granted U.S. patents for ultrasonic wireless power transmission (source: Google Patents, J. Craig Venter Institute board biography). The U.S. Patent and Trademark Office does not grant patents for technology that was merely “claimed.” This phrasing implies the technology was fictitious, which no reliable source supports. Per WP:PEACOCK and WP:LABEL, Wikipedia should not use loaded characterizations where neutral language exists.

(b) Defining a living person primarily by a defunct company is inappropriate under WP:BLP. The company in question changed its name to SonicEnergy and is reported to have ceased operations in 2024. The subject left the company in 2018 — nearly eight years ago — and has since co-founded Elemind Technologies, which has published peer-reviewed clinical research in Nature Portfolio journals and shipped a commercial product. Anchoring the biography’s opening sentence to a company that no longer exists under its original name, rather than to the subject’s actual body of work as an inventor, does not serve the reader and raises BLP concerns about defining a living person by a negative characterization of a former employer.

(c) “Did not succeed in producing a commercial product” in the opening line is editorializing. The article body already covers the company’s history, criticism, and commercial outcome in appropriate detail. Frontloading the very first sentence with a failure characterization, before any mention of the subject’s patents, current work, or recognition, violates WP:NPOV and WP:DUE for a biography of a living person. By comparison, the opening lines of biographies of other founders whose companies did not reach commercial success (e.g., many deep-tech and biotech founders) typically describe the subject’s field of work, not the commercial outcome of a single venture.

The proposed language — “best known as the inventor of ultrasonic wireless power transmission” — is verifiable (25 granted patents, PennVention competition win sourced in the article itself, coverage in Fortune, NPR, USA Today, and the New York Times describing the subject as the inventor of the technology). The full history of uBeam, including criticism and commercial outcome, remains in the article body where it can be presented with appropriate context and sourcing.

Sources: US9094111B2 — Receiver transducer for wireless power transfer (granted patent, inventor: Meredith Perry) US20120299540A1 — Sender communications for wireless power transfer (inventor: Meredith Perry) J. Craig Venter Institute biography: “She has been awarded 25 patents with an additional five pending.” Fortune (2014): “Meet the 25-year-old inventor working on wireless charging technology” SonicEnergy Wikipedia article: documents the company’s name change and reported closure in 2024

Proposed Edit 2: Elemind section — update with peer-reviewed clinical trial and correct terminology

Current text: On February 6, 2024, Elemind emerged from stealth mode, with Perry saying that its wearable device could “stop tremor for people with essential tremors” and “induce sleep, faster than leading sleep drugs”, as well as assist in memory formation and pain management, although no device image was released at that time.

Proposed text: On February 6, 2024, Elemind emerged from stealth mode, with Perry saying that its wearable device could “suppress tremor for people with essential tremors” and “induce sleep, faster than leading sleep drugs”, as well as assist in memory formation and pain management. In June 2024, the company published a randomized controlled clinical trial in Scientific Reports (Nature Portfolio), reporting that acoustic stimulation delivered by its wearable headband significantly reduced sleep onset latency in adults with insomnia (p=0.0019), with 76% of participants experiencing improvement relative to a sham control. Third-party coverage of the study appeared in MIT News. Elemind’s headband is now commercially available.

Rationale: (a) “Stop tremor” → “suppress tremor” corrects the quoted language to match published scientific literature. The subject’s published research and public statements use “suppress,” not “stop.” (b) The clinical trial is a WP:MEDRS-compliant source. It is a randomized controlled trial published in a peer-reviewed journal (Scientific Reports, Nature Portfolio), indexed in PubMed (PMID: 38844793), and registered on ClinicalTrials.gov (NCT05743114). Third-party coverage from MIT News satisfies WP:SECONDARY. (c) “Although no device image was released at that time” is outdated trivial detail. The device has since shipped commercially and images are widely available. This clause adds no encyclopedic value and should be removed per WP:TRIVIA.

Sources: Bressler S, Neely R, Yost RM, Wang D. “A randomized controlled trial of alpha phase-locked auditory stimulation to treat symptoms of sleep onset insomnia.” Scientific Reports 14 (2024). DOI: 10.1038/s41598-024-63385-1 MIT News / MedicalXpress: “Headband helps people fall asleep by aligning audio signals with brainwaves” ClinicalTrials.gov NCT05743114

I welcome feedback from uninvolved editors on both proposals. Berlinwhalel1989 (talk) 02:51, 31 March 2026 (UTC)[reply]

• What I think should be changed:This article has been subject to ongoing edit wars and I am requesting page protection to preserve the current version against further disruptive, non-neutral edits. The prior version of this article contains multiple WP:BLP and WP:NPOV violations that I want to flag for administrators:

1. Non-neutral lead sentence: The opening reads: “best known as the founder of uBeam, a company that claimed to develop wireless charging technology using ultrasound but did not succeed in producing a commercial product.” The word “claimed” implies dishonesty or deception rather than neutrally describing the company’s work. Placing an editorial negative conclusion (“did not succeed”) in the very first sentence of a biography of a living person violates WP:BLP, which requires that BLPs be “written conservatively” and “in a dispassionate tone, avoiding both understatement and overstatement.” Leading with a negative conclusion in the opening sentence is inconsistent with this standard and gives WP:UNDUE weight to one aspect of the subject’s career. 2. Editorializing the TEDx talk: The article states Perry “argued that engineers are inherently linear thinkers,” followed immediately by “Commentators later contrasted these claims with the doubts raised by experts.” The word “argued” is editorial rather than neutral (compare: “discussed,” “described,” or “said”). Characterizing her talk as making “claims” that are then debunked in the next sentence creates a non-neutral framing that is inconsistent with WP:NPOV. 3. Outdated and misleading editorial aside on Elemind: The Elemind section ends with “although no device image was released at that time.” This editorial aside was clearly written to cast doubt on whether the product exists. As of 2024–2025, Elemind is a commercially shipping consumer product available for purchase, which makes this aside not only non-neutral but factually misleading to current readers. 4. Structural imbalance: The “Recognition and reception” section re-states criticism of uBeam that was already covered in the uBeam section, effectively doubling the negative framing. Meanwhile, the article contains no mention of Perry’s peer-reviewed publications in Nature portfolio journals, her 8 granted patents (4 jointly with MIT), Elemind’s £6.3M MRC research grant with Imperial College London for Alzheimer’s and sleep research, her co-founding of Elemind with MIT and Imperial College neuroscientists including Ed Boyden, or her board membership at the J. Craig Venter Institute. This structural imbalance — heavy on criticism, light on verifiable accomplishments — violates WP:NPOV and WP:BLP. 5. Pattern of edit warring: This article has been subject to recurring edit wars over an extended period. I am requesting semi-protection or full protection to prevent further disruptive editing on this BLP article.

Why it should be changed: WP:BLP requires that biographies of living persons be “written conservatively and with regard for the subject’s privacy” and that “contentious material about living persons that is unsourced or poorly sourced should be removed immediately.” The prior version of this article violates these principles through editorialized language (“claimed,” “argued,” “did not succeed” in the lead), outdated information presented to cast doubt (the “no device image” aside), and structural imbalance that weights criticism far above verifiable accomplishments. The ongoing edit warring on this article further warrants page protection under WP:EDITWAR and WP:PP. References supporting the possible change (format using the “cite” button):

• • Perry, M. et al. — Peer-reviewed publications in Nature portfolio journals (verifiable via PubMed and Google Scholar under “Elemind” and “closed-loop acoustic neuromodulation”)
  • USPTO records — 8 granted patents, 4 jointly with MIT (searchable by inventor name “Meredith Perry”)
  • UKRI Gateway to Research — 6.3M MRC grant with Imperial College London, “Closed-loop auditory stimulation for sleep and dementia”
  • Elemind Technologies commercial product — available at elemindtech.com, commercially shipping consumer product as of 2024
  • J. Craig Venter Institute Board of Trustees — https://www.jcvi.org/about/meredith-perry
  • Elemind co-founders include Ed Boyden (MIT), Nir Grossman (Imperial College London), David Wang (MIT PhD), Heather Read (UConn) — verifiable via https://elemindtech.com/pages/about-us
  • Forbes “30 Under 30,” Fortune “Most Powerful Women,” Vanity Fair “The New Establishment,” Fast Company “Most Creative People,” Elle “Genius Award” — all previously cited in the article itself

Berlinwhalel1989 (talk) 17:05, 26 April 2026 (UTC)[reply]